Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Because these therapies include both GLP-1 and GIP receptor agonists, our weight loss medications can offer superior appetite suppression and metabolic benefits compared to GLP 1 alone
For tirzepatide, 4 days
The SURMOUNT-5 clinical trial published in The New England Journal of Medicine showed that Zepbound (tirzepatide) achieved an average weight loss of 20.2% compared to 13.7% with Wegovy (semaglutide) at 72 weeks
The effects of your prescribed medicine will start to wear off after about a day (if youre on Saxenda weight loss injections) or a week (Wegovy and Mounjaro), which could cause your appetite to dial back up
The other three DPP-4 inhibitors, teneligliptin, anagliptin and trelagliptin, are only approved in the Japanese and Korean markets
Commonly prescribed as part of a medically supervised weight management program
US$ 29.26
US$ 23.13
)
US$ 27.52
)
US$ 24.94
